Log in to the research portal to view current pricing, stock, and bundles and order.
Cognitive & Neurological research peptides in this catalog
Why neuropeptides are studied in the nervous system
Neuropeptides are signaling molecules that neurons synthesize, store, and release to modulate the activity of other neurons and glial cells. Unlike fast-acting classical neurotransmitters such as glutamate and GABA, neuropeptides typically act through G-protein-coupled receptors and produce slower, longer-lasting modulatory effects on neural circuits. The research literature describes them as fine-tuning agents that adjust the gain of synaptic transmission rather than directly carrying the primary excitatory or inhibitory signal.
The peptides grouped in this category have been examined in rodent models and cell culture systems because they appear, in published preclinical work, to interact with these modulatory pathways. Investigators study how these molecules influence neuronal survival, gene expression for neurotrophic factors, and the balance of excitatory and inhibitory tone. This research framing is strictly mechanistic and observational, conducted in non-human systems.
It is important to frame this entire category accurately. Nothing described here constitutes evidence of an effect in a person, and none of these compounds is offered as a way to improve human cognition, mood, or focus. The descriptions below summarize what has been reported in the scientific record for research organisms and isolated cells, and the compounds are supplied for that controlled research context alone.
BDNF and neurotrophic mechanisms
Brain-derived neurotrophic factor (BDNF) is a member of the neurotrophin family that supports the survival of existing neurons and, in preclinical models, encourages the growth and differentiation of new neurons and synapses. BDNF binds the TrkB receptor and activates downstream cascades including MAPK/ERK, PI3K/Akt, and PLC-gamma, which are studied for their roles in neuronal gene transcription and dendritic remodeling. Because BDNF sits at the center of so much neuroplasticity research, peptides that appear to modulate its expression are of significant interest to laboratories.
Several compounds in this category have been reported in animal studies to influence BDNF levels or downstream neurotrophic signaling. Semax and its derivatives, for example, are described in rodent literature as upregulating BDNF and its receptor in the hippocampus. This is one reason the regulatory peptides and the neurotrophic mixtures in this group are frequently examined side by side, since both intersect with neurotrophin biology through different upstream routes.
Synaptogenesis, the formation of new synaptic connections, and long-term potentiation, a cellular correlate of learning in animal models, are common readouts in this research area. Investigators use electrophysiology, immunohistochemistry, and gene-expression assays to characterize how a test peptide changes these endpoints in cultured neurons or in defined brain regions of laboratory animals.
Regulatory peptides versus neurotrophic compounds
A useful distinction within this category separates the short regulatory peptides from the neurotrophic compounds. Selank and Semax are regulatory peptides: small synthetic sequences derived from endogenous human peptides that, in preclinical models, modulate existing neurochemical systems. Selank is a synthetic analog of the immunomodulatory peptide tuftsin, and Semax is a synthetic fragment related to adrenocorticotropic hormone. Their reported activity in animal studies centers on adjusting neurotransmitter tone and neuropeptide signaling rather than supplying a growth-factor payload.
Cerebrolysin and Dihexa fall on the neurotrophic side, though by very different routes. Cerebrolysin is a mixture of low-molecular-weight peptides and amino acids derived from porcine brain tissue, studied as a neurotrophic and neurorestorative preparation that appears in models to mimic the action of endogenous neurotrophic factors. Dihexa is a small synthetic peptide investigated for its reported activity on the hepatocyte growth factor (HGF) and its receptor c-Met, a pathway tied in research to synapse formation.
This regulatory-versus-neurotrophic framing helps researchers organize comparisons. Regulatory peptides are typically studied for modulation of mood-related and stress-related circuitry in animals, while neurotrophic compounds are studied for neuronal survival, repair, and synaptogenesis endpoints. The categories overlap at the level of BDNF and downstream plasticity, which is why the literature often treats them as a single research family.
Selank and neuropeptide modulation of GABA and serotonin
Selank is studied in animal models for its reported anxiolytic-like profile, with published preclinical work describing modulation of the GABAergic and serotonergic systems. Investigators have examined how Selank influences the expression of genes related to GABA-A receptor subunits and how it appears to affect serotonin metabolism in rodent brain tissue. As a tuftsin analog, it is also studied for interactions between immune signaling peptides and central neurochemistry.
A frequently cited feature in the Selank literature is its reported stability relative to the native peptide it is modeled on, which makes it more tractable for controlled experiments. Researchers studying anxiety-related behavior in animals use Selank as a tool compound to probe how neuropeptide modulation of inhibitory tone manifests in standardized behavioral assays, always within a non-human research setting.
This work is mechanistic and conducted in research organisms. It does not establish any calming or anxiety-reducing effect in people, and Selank is supplied only for in-vitro and animal research, not for consumption.
Semax, ACTH(4-10) analogs, and the melanocortin-BDNF link
Semax is a synthetic heptapeptide based on the ACTH(4-10) fragment, a region of adrenocorticotropic hormone that lies within the melanocortin signaling family. Unlike full ACTH, the fragment Semax is modeled on is studied for neuromodulatory rather than hormonal effects. Preclinical literature describes Semax influencing the melanocortin system and, downstream, the expression of BDNF and nerve growth factor in specific brain regions of rodents.
Researchers examine Semax in models of neuroplasticity and neuroprotection, measuring changes in neurotrophin expression, neuronal survival under stress, and behavior in standardized animal paradigms. The ACTH(4-10) lineage connects Semax to a broad body of work on melanocortin peptides and their reported roles in attention-related and adaptive circuitry in animals.
Because the native peptide sequence is rapidly degraded by peptidases, the practical research value of Semax depends heavily on how it is formulated and stabilized, which is the focus of the modification chemistry section below.
Cerebrolysin: neuroprotective and neurorestorative peptide mixtures
Cerebrolysin is distinct from the single-sequence synthetic peptides in this category because it is a defined mixture of low-molecular-weight neuropeptides and free amino acids produced by the enzymatic breakdown of purified porcine brain proteins. In preclinical research it is studied as a neurotrophic and neurorestorative preparation, with reported effects in models that resemble those of endogenous neurotrophic factors such as BDNF and glial-cell-line-derived neurotrophic factor.
Animal and cell-culture studies have examined Cerebrolysin for endpoints including neuronal survival after injury, reduction of excitotoxic damage, modulation of amyloid-related processing in disease models, and support of synaptic structure. Because it is a mixture rather than a single molecule, characterization emphasizes lot consistency and the reproducibility of its peptide profile across batches.
The neurorestorative framing makes Cerebrolysin a common comparator in research that pits a complex biological mixture against a defined synthetic peptide, helping investigators ask whether a single mechanism or a multi-component approach better reproduces a given neurotrophic readout in their model.
Dihexa and the HGF/c-Met pathway
Dihexa is a small synthetic peptide investigated for its reported interaction with hepatocyte growth factor (HGF) and its receptor, the c-Met tyrosine kinase. The HGF/c-Met system, while widely known for roles outside the nervous system, has been studied in the brain for its involvement in synaptogenesis and dendritic spine formation. Dihexa is described in preclinical literature as a compound that appears to potentiate this pathway, positioning it among the most mechanistically specific molecules in this category.
Research interest in Dihexa centers on its reported potency in promoting synapse formation in cultured neurons and in animal models, and on its apparent metabolic stability relative to the angiotensin-derived peptides it descends from. Investigators use it as a tool to probe whether augmenting HGF/c-Met signaling produces measurable changes in synaptic density and connectivity in non-human systems.
As with every compound here, the Dihexa research record is confined to cells and animals. No conclusion about human cognition can be drawn from it, and it is offered strictly for laboratory research.
Modification chemistry and stability: N-Acetyl Semax Amidate versus Semax
Short peptides are vulnerable to enzymatic degradation, particularly by exopeptidases that trim residues from the N-terminus and C-terminus. N-Acetyl Semax Amidate is a modified form of Semax engineered to resist this degradation: acetylation of the N-terminal amino group and amidation of the C-terminal carboxyl group block the recognition sites that peptidases use, which research describes as extending the molecule's functional half-life relative to unmodified Semax.
These terminal modifications are a textbook example of how peptide chemistry trades a small structural change for a meaningful difference in stability and, often, in apparent potency in experimental systems. Investigators comparing Semax with N-Acetyl Semax Amidate can isolate the contribution of stabilization to an observed effect, since the core sequence is shared and only the protecting groups differ.
Understanding these chemistry differences matters for experimental design. A more stable analog may produce a stronger or more durable signal in a given assay simply because more intact peptide reaches the target, which is a confound researchers must account for when interpreting results across the two forms.
Blood-brain barrier and intranasal research delivery
A central challenge in neuropeptide research is delivery to the central nervous system, because the blood-brain barrier restricts the passage of most peptides from the periphery into brain tissue. Much of the preclinical literature on Selank, Semax, and related compounds therefore examines intranasal administration in animal models, a route studied for its potential to provide more direct access to the brain along olfactory and trigeminal pathways while bypassing first-pass metabolism.
Researchers studying these delivery questions measure how formulation, concentration, and terminal stability interact with route of administration to determine how much intact peptide reaches central targets in a research organism. Stabilized analogs such as N-Acetyl Semax Amidate are of particular interest here, since resistance to degradation is relevant at every step from administration site to target tissue.
These delivery considerations are part of the experimental methodology, not instructions for use. The compounds are handled in laboratory settings according to research protocols and are not intended for administration to humans or animals.
Research application areas
Choosing a compound for your research
Match the compound to the mechanism under study: choose Selank or Semax when the question concerns neuropeptide modulation of existing neurotransmitter systems, and Cerebrolysin or Dihexa when the question concerns neurotrophic support or synaptogenesis.
For HGF/c-Met pathway work specifically, Dihexa is the relevant tool compound, since its reported activity is tied directly to that receptor system rather than to broad neurotransmitter modulation.
When stability is a variable of interest, pair Semax with N-Acetyl Semax Amidate so the shared core sequence isolates the contribution of N-terminal acetylation and C-terminal amidation.
Choose Cerebrolysin when the experimental design calls for a multi-component neurotrophic mixture as a comparator against a single defined synthetic peptide; confirm lot-to-lot peptide profile consistency before relying on it.
For BDNF-focused expression studies, Semax and its amidated analog are the most directly relevant, given the rodent literature linking them to neurotrophin upregulation.
Always confirm purity, sequence verification, and certificate of analysis documentation before designing an experiment, and account for differing stability profiles when comparing compounds head to head.
Per-compound reference data: Selank reference · Semax reference · Pinealon reference · Adamax reference.
Frequently asked questions
What are cognitive and neurological research peptides?
They are short synthetic peptides and defined peptide mixtures studied in vitro and in animal models for reported effects on neurotrophic signaling, synaptic plasticity, and neuropeptide modulation of the central nervous system. This category includes Selank, Semax, Cerebrolysin, Dihexa, and N-Acetyl Semax Amidate. They are research reagents only, not approved by the FDA, and not intended for human or animal consumption or for any diagnostic or therapeutic purpose.
How do these compounds relate to BDNF?
BDNF is a neurotrophin that supports neuronal survival and, in preclinical models, drives synaptic plasticity through the TrkB receptor. Several compounds in this category, notably Semax and its amidated analog, are reported in rodent studies to influence BDNF expression in regions such as the hippocampus. Cerebrolysin is studied as a mixture that appears to mimic neurotrophic factor action. These observations are mechanistic findings in non-human research systems only.
What is the difference between regulatory peptides and neurotrophic compounds here?
Regulatory peptides such as Selank and Semax are short synthetic sequences derived from endogenous human peptides that, in animal models, modulate existing neurochemical systems like GABA and serotonin signaling. Neurotrophic compounds such as Cerebrolysin, a porcine-derived peptide mixture, and Dihexa, an HGF/c-Met pathway peptide, are studied for neuronal survival, repair, and synaptogenesis. The two groups overlap at the level of BDNF and downstream plasticity.
Why is N-Acetyl Semax Amidate different from Semax?
N-Acetyl Semax Amidate is a modified version of Semax with two terminal changes: acetylation of the N-terminus and amidation of the C-terminus. These modifications block the sites that peptidases use to degrade the molecule, which research describes as increasing stability and functional half-life relative to unmodified Semax. Because the core sequence is shared, comparing the two forms lets researchers isolate how stabilization affects observed activity in experimental systems.
What is the HGF/c-Met pathway and how does Dihexa fit in?
The HGF/c-Met pathway involves hepatocyte growth factor binding the c-Met receptor tyrosine kinase, a system studied in the brain for roles in synaptogenesis and dendritic spine formation. Dihexa is a small synthetic peptide investigated for its reported ability to potentiate this pathway, making it the most mechanistically specific compound in this category. Research interest centers on synapse formation endpoints in cultured neurons and animal models, strictly in non-human systems.
How should these research peptides be reconstituted and stored?
Lyophilized research peptides are typically reconstituted with a suitable sterile solvent such as bacteriostatic or sterile water following the supplier protocol and certificate of analysis. Reconstituted peptides are generally kept refrigerated for short-term laboratory use and frozen for longer-term storage, with repeated freeze-thaw cycles minimized to preserve integrity. Always verify purity and sequence documentation. These handling notes are for laboratory research only; products are not for human or animal consumption.
Create a free research account to view current pricing, real-time stock, and bundle options, then submit your order for approval.
Related: What are peptides? · Reference library · Cost & pricing · Price comparison · Research guides · Order portal